跳转至内容
Merck
CN

Silver nitrate prophylaxis.

Canadian Medical Association journal (1984-08-01)
G Schneider
摘要

In many countries the statutory use of silver nitrate prophylaxis as soon as possible after birth has recently been reviewed from both a human rights and a medical standpoint. It has been argued that silver nitrate does not prevent all cases of gonococcal ophthalmia neonatorum (GON) and that it causes chemical conjunctivitis, pain and visual impairment, which may interfere with parent-infant bonding. Furthermore, the low incidence of GON, better methods of prenatal diagnosis, and the availability of suitable alternative prophylactic medication and of effective methods of treatment of GON have prompted recommendations that alternative prophylaxis be legally allowed or that mandatory prophylaxis be eliminated altogether. This paper reviews the situation and provides updated recommendations.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
硝酸银, ACS reagent, ≥99.0%
Sigma-Aldrich
硝酸银, ReagentPlus®, ≥99.0% (titration)
Sigma-Aldrich
硝酸银, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8%
Sigma-Aldrich
硝酸银, 99.9999% trace metals basis
Sigma-Aldrich
硝酸银, meets analytical specification of Ph. Eur., BP, USP, 99.8-100.5%
Sigma-Aldrich
硅胶负载硝酸银, extent of labeling: ~10 wt. % loading, +230 mesh
Sigma-Aldrich
硝酸银 溶液, 2.5 % (w/v) AgNO3 in H2O
Sigma-Aldrich
硝酸银, puriss. p.a., ≥99.5% (AT)
Sigma-Aldrich
硝酸银, BioReagent, suitable for plant cell culture, >99% (titration)
Sigma-Aldrich
硝酸银, BioXtra, >99% (titration)
Sigma-Aldrich
硝酸银, tested according to Ph. Eur.